Results 31 to 40 of about 863,398 (307)

Progression of disease within 24 months (POD24) in multiple myeloma implicates poor prognosis and limitations of current prediction models for POD24

open access: yesScientific Reports
Multiple myeloma (MM) is a common hematological malignancy, and its prognostic factors have been extensively studied. Progression of disease within 24 months (POD24) suggests a poor prognosis in many malignancies, but is rarely mentioned in MM.
Yongqin Cao   +5 more
doaj   +1 more source

Distinct clinico-genomic factors drive outcomes in patients with myelofibrosis and disease-related anemia

open access: yesFrontiers in Hematology
BackgroundDisease related anemia in myelofibrosis (MF) is common and prognostically detrimental. Anemia in MF poses a therapeutic challenge as it contributes to poor quality of life and often interferes with JAK inhibitor therapy.
Somedeb Ball   +11 more
doaj   +1 more source

Establish immune-related gene prognostic index for esophageal cancer

open access: yesFrontiers in Genetics, 2022
Background: Esophageal cancer is a tumor type with high invasiveness and low prognosis. As immunotherapy has been shown to improve the prognosis of esophageal cancer patients, we were interested in the establishment of an immune-associated gene ...
Caiyu Guo   +6 more
doaj   +1 more source

Operational Prognostic Model Evaluation

open access: yesPHM Society Asia-Pacific Conference, 2023
Prognostic analytic models have become a viable way to reduce operational interruptions when sufficient timely data is available. This work describes a set of evaluation metrics which can characterize model performance as a degradation estimate and as a decision enabler.
Shashvat Prakash   +2 more
openaire   +1 more source

A Similarity-Based Prognostics Approach for Remaining Useful Life Prediction [PDF]

open access: yes, 2014
Physics-based and data-driven models are the two major prognostic approaches in the literature with their own advantages and disadvantages. This paper presents a similarity-based data-driven prognostic methodology and efficiency analysis study on ...
Camci, Faith   +2 more
core   +1 more source

Circuit breaker prognostics using SF6 data [PDF]

open access: yes, 2011
Control decisions within future energy networks may take account of the health and condition of network assets, pushing condition monitoring within the smart grid remit.
Catterson, Victoria   +3 more
core   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysis

open access: yesFrontiers in Oncology, 2022
Acute myeloid leukemia (AML) is a highly heterogeneous hematological malignancy. The bone marrow (BM) microenvironment in AML plays an important role in leukemogenesis, drug resistance and leukemia relapse.
Fu Li   +7 more
doaj   +1 more source

Stochastic RUL calculation enhanced with TDNN-based IGBT failure modeling [PDF]

open access: yes, 2016
Power electronics are widely used in the transport and energy sectors. Hence, the reliability of these power electronic components is critical to reducing the maintenance cost of these assets.
Alghassi, Alireza   +2 more
core   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Home - About - Disclaimer - Privacy